絞り込み

16501

広告

ADJUVITE: a double-blind, randomised, placebo-controlled trial of adalimumab in early onset, chronic, juvenile idiopathic arthritis-associated anterior uveitis.

著者 Quartier P , Baptiste A , Despert V , Allain-Launay E , Koné-Paut I , Belot A , Kodjikian L , Monnet D , Weber M , Elie C , Bodaghi B ,
Ann Rheum Dis.2017 Dec 23 ; ():.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (20view , 0users)

Full Text Sources

Medical

To assess the efficacy and safety of adalimumab on uveitis in patients with early onset, chronic, juvenile idiopathic arthritis (JIA)-associated or idiopathic anterior uveitis and an inadequate response to topical steroids and methotrexate (MTX).
PMID: 29275333 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード